CARM1 and breast carcinoma: In contrast to its high expression in breast cancer (Wang et al., 2014), the greatly repressed expression of PRMT4 in PDAC cells also suggested that the pathogenic roles of PRMT4 in pancreatic cancer might be mediated by tissue-specific signaling mechanisms.